Axovant Gene Therapies

AXGT NASDAQ
5.67
+0.09
+1.61%
交易中 09:31 06/20 EDT
开盘
5.75
昨收
5.58
最高
5.85
最低
5.67
成交量
5.21万
成交均量(3M)
27.97万
52周最高
24.32
52周最低
3.810
换手率
0.23%
市值
1.29亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Axovant Gene Therapies AXGT股票价格,Axovant Gene Therapies股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Axovant Gene Therapies Ltd., formerly Axovant Sciences Ltd., is a clinical-stage biopharmaceutical company. The Company is focused on acquiring, developing and commercializing therapeutics for the treatment of dementia, including Alzheimer's disease and Lewy body dementia. The Company intends to develop a pipeline of product candidates to address the cognitive, functional and behavioral aspects of dementia and related neurological disorders. The Company also focuses on developing nelotanserin, a selective 5-hydroxytryptamine 2A receptor inverse agonist, for the treatment of rapid eye movement (REM) behavior disorder (RBD) in DLB patients, and visual hallucinations in patients with Lewy body dementia. Its AXO-Lenti-PD is an in vivo lentiviral gene therapy investigational product candidate and being developed for the one-time treatment of Parkinson’s disease.
展开 >

最近浏览

名称
价格
涨跌幅